Ainos Reports $4.6M Q2 Loss on Near-Zero Revenue, Cash Drops to $1.4M
AIMD sits 21% above its 52-week low of $1.26 on light trading volume (0.1× avg).
Summary
Ainos posted a $4.6 million Q2 loss on near-zero revenue, leaving only $1.4 million in cash. The going concern warning persists, and the company's survival hinges on continued dilutive financing.
Key Events · Earnings and Guidance · AIMD
-
Q2 Net Loss of $4.6M
Net loss widened to $4.6 million from $4.1 million a year ago, driven by R&D and SG&A expenses, with revenue collapsing to $152.
-
Cash Plummets to $1.4M
Cash and equivalents fell to $1.4 million as of June 30, 2026, from $7.6 million in equity at year-end 2025, after burning through cash and converting debt.
-
Going Concern Warning Reiterated
The company continues to express substantial doubt about its ability to continue as a going concern, consistent with the recent 10-Q filed today.
-
AI Nose Commercialization Progress
AI Nose has accumulated 613 million industrial smell data records and expanded deployments in semiconductor, healthcare, and robotics, but revenue remains negligible.
Analysis · AIMD · Technology
Ainos burned through most of its cash, ending Q2 with only $1.4 million — down from $7.6 million in equity six months ago — while generating just $152 in revenue. The company continues to rely on dilutive ATM sales and related-party loans to stay afloat, and the going concern warning remains. The operational update highlights AI Nose deployments and 613 million data records, but these have yet to translate into meaningful revenue. With a $4.6 million quarterly loss, the current cash barely covers one month of operations, making further dilution or financing almost certain.
At the time of this filing, AIMD was trading at $1.52 on NASDAQ in the Technology sector, with a market capitalization of approximately $12.4M. The 52-week trading range was $1.26 to $4.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.